Defeating Asthma Series uncovers New Hope for Asthma Management In this third interview with Martin J Blaser MD, Director of the Center for Advanced Biotechnology and Medicine at Rutgers Biomedical and Health Sciences and the Henry Rutgers Chair of the…
Asthma and Indoor Air Pollution:
Key insights for Asthmatics: Makes Asthma Worse Significant Association with Exacerbations Among this panel of relatively moderate to severe asthmatics, the respiratory irritants produced by several domestic combustion sources were associated with increased morbidity. Although there is abundant clinical evidence…
Asthma and Gut Health
The gut and lungs are anatomically distinct, but potential anatomic communications and complex pathways involving their respective microbiota have reinforced the existence of a gut–lung axis (GLA). Compared to the better-studied gut microbiota, the lung microbiota, only considered in recent…
Non-Eosinophilic Asthma (NEA)
Although non-eosinophilic asthma (NEA) is not the best known and most prevalent asthma phenotype, its importance cannot be underestimated. NEA is characterized by airway inflammation with the absence of eosinophils, subsequent to activation of non-predominant type 2 immunologic pathways. This…
Study assesses asthma treatment options in African American children and adults
Use of long-acting bronchodilators had no impact for some African American children. A new study of African Americans with poorly controlled asthma, found differences in patients’ responses to commonly used treatments. Contrary to what researchers had expected, almost half of…
Protein found in patients with severe asthma can help identify who would benefit from targeted drugs
Novel study establishes that airways periostin is the expression of type 2 endotype severe asthma and helps identify which patients may benefit from newly developed treatments and improved quality of life, report researchers in the journal CHEST® Glenview, IL, October…